IGF1 and cancer: The GH/IGF-1 pathway and its downstream effectors including target of rapamycin (TOR), protein kinase A (PKA) and the ribosomal protein S6 kinase (S6K) are reported to promote aging and age-related diseases, including cancer, in several model organisms [22].